Name: Relucio, Jessica P.

Group 112
Drug Name & Dosage, Frequency & Action/Classification Indication Contraindication Adverse Effect Nursing
Brand Name Preparation Responsibility
Generic Available forms: Potent Treatment metastatic Contraindicated CNS: depression, Alert women
name: Tablets – 10,20 mg; antiestrogenic breast cancer in with allergy to lightheadedness, with DCIS and
Tamoxifen oral solution – effects: women and men; in tamoxifen, dizziness, headache, those at high
Citrate 10mg/5ml Competes premenopausal pregnancy, corneal opacity, risk for breast
with estrogen women with lactation, women decreased visual cancer of risks
Brand Adults: for binding metastatic breast who require acuity, retinopathy, for serious
name: Breast cancer: 20- sites in tissues, cancer; tamoxifen is concomitant CVA. potentially
Apo- 40 mg/day PO for 5 such as the an alternative to coumarin-type fatal drug
Tamox, yrs. dosages of breast. oophorectomy or anticoagulation Dermatologic: effects; discuss
Solatamox, more than 20 ovarian irradiation. therapy or in Steven-Johnson benefits versus
Tamofen mg/day should be women with syndrome, hot risks.
given in divided Treatment of node history of DVT or flushes, rash.
doses, morning positive breast cancer PE. Administer bid
and evening. in post menopausal GI: nausea and in the morning
Reduction in breast women following vomiting, food and the
cancer incidence: total mastectomy or Use cautiously in distaste, alterations evening.
20mg/day PO for 5 segmental women with a in liver enzyme.
yrs. mastectomy, axillary history of Counsel
dissection and breast thromboembolic GU: vaginal patient use
irradiation. events. bleeding vaginal contraception
discharge, menstrual while taking
Treatment of axillary irregularities, this drug;
node negative breast pruritus vulvae, inform patient
cancer following total endometrial cancer, that serious
mastectomy or uterine carcinoma, fetal harm
segmental could occur.
mastectomy, axillary Hematologic:
dissection and breast hypercalcemia, Have regular
irradiation. especially with bones gynecologic
metastases, examinations
Reduction in risk of thrombocytopenia, during therapy.
invasive breast cancer leucopenia, anemia,
in women with ductal DVT. Report marked
carcinoma in situ weakness,
(DCIS) following Other: peripheral sleepiness,
breast surgery and edema increased mental
radiation. bone and tumor pain confusion, pain
and local disease, or swelling of
Reduction in cancer in animal the legs,
occurrence of studies, changes in shortness of
contralateral breast LFTs, PE. breath, blurred
cancer in patient vision.
receiving adjuvant
tamoxifen therapy for
breast cancer.

Reduction in
incidence of breast
cancer in women at
high risk for breast
cancer.

Unlabeled use:
treatment of
mastalgia; use for
decreasing pain and
size of gynecomastia.